BEUDAMED
    12 results · 20ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Country: United States ×

    NA

    FDA UDI
    KEY SURGICAL, INC.·10849771049934·Steinmann Pins, Single diamond, round end, 3/32...

    Key Surgical K-Wires and Steinmann Pins

    FDA UDI
    KEY SURGICAL, INC.·00849771015079·Steinmann Pins, Single diamond, round end, 3/32...

    KMEDIC

    FDA UDI
    TELEFLEX INCORPORATED·24026704293791·

    KMEDIC

    FDA UDI
    TELEFLEX INCORPORATED·14026704912442·

    mahe medical GmbH

    FDA UDI
    mahe medical gmbh·04050659485174·Steinmann pin w. lanzet/round end _x000D_...

    Steinmann pin w. lanzet/round end 2.4mm/229mm, 6 pcs./unit

    FDA UDI
    mahe medical gmbh·EMAHKM716630·Steinmann pin w. lanzet/round end 2.4mm/...

    PROBE & CATHETER

    FDA 510(k)
    FDA Class 2 ·Cardiovascular

    VF GEL PLUS

    FDA 510(k)
    FDA Class 2 ·Ear, Nose, Throat

    ACCU-CHEK RAPID-D

    FDA Adverse Event
    Malfunction ·ROCHE HEALTH SOLUTIONS INC.·Product code FPA·January 30, 2013

    COULTER® HMX HEMATOLOGY ANALYZER WITH AUTOLOADER

    FDA Adverse Event
    Malfunction ·BECKMAN COULTER INC.·Product code GKZ·January 27, 2011

    DXTEND GLENOSPHERE STD D38MM

    FDA Adverse Event
    Injury ·DEPUY FRANCE S.A.S.-SAINT PRIEST 3003895575·Product code HSD·July 31, 2014

    Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

    FDA Enforcement
    Class II ·Terminated·St Jude Medical Inc.·October 25, 2017